Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.00001 par value per share
-
Shares outstanding
-
4,564,846
-
Total 13F shares
-
93,345,592
-
Share change
-
+17,614,617
-
Total reported value
-
$1,599,320,942
-
Put/Call ratio
-
63%
-
Price per share
-
$17.13
-
Number of holders
-
120
-
Value change
-
+$283,166,441
-
Number of buys
-
92
-
Number of sells
-
20
Institutional Holders of RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) as of Q4 2021
As of 31 Dec 2021 RECURSION PHARMACEUTICALS, INC. - Class A Common Stock, $0.00001 par value per share (RXRX) had 120 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 93,345,592 shares of stock of the company.
Largest 10 holders included BAILLIE GIFFORD & CO, BlackRock Inc., VANGUARD GROUP INC, Obvious Management Services, L.L.C., Data Collective IV GP, LLC, STATE STREET CORP, DCVC Opportunity Fund II GP, LLC, Laurion Capital Management LP, ALLIANCEBERNSTEIN L.P., and ARK Investment Management LLC.
This table shows 120 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.